IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,447,850 | -40.5% | 1,448,432 | -2.1% | 0.00% | – |
| Q2 2023 | $4,111,489 | +40.0% | 1,478,953 | -8.3% | 0.00% | – |
| Q1 2023 | $2,936,000 | +37681.5% | 1,613,297 | +5.2% | 0.00% | -100.0% |
| Q4 2022 | $7,771 | -99.9% | 1,533,127 | -1.9% | 0.00% | 0.0% |
| Q3 2022 | $7,769,000 | +79.8% | 1,563,263 | +34.5% | 0.00% | 0.0% |
| Q2 2022 | $4,322,000 | -35.2% | 1,161,894 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $6,671,000 | -13.7% | 1,189,163 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $7,729,000 | -33.6% | 1,271,192 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $11,643,000 | +30.9% | 1,195,309 | +91.9% | 0.00% | 0.0% |
| Q2 2021 | $8,896,000 | -31.1% | 623,024 | +14.6% | 0.00% | -50.0% |
| Q1 2021 | $12,908,000 | – | 543,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $933,271 | 0.26% |
| ALLEN HOLDING INC /NY | 687,571 | $1,911,447 | 0.26% |
| Clearwater Capital Advisors, LLC | 394,599 | $1,096,986 | 0.13% |
| SHEETS SMITH WEALTH MANAGEMENT | 269,129 | $748,179 | 0.11% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $268,084 | 0.10% |
| WEALTH EFFECTS LLC | 71,000 | $197,380 | 0.09% |
| Virtus ETF Advisers LLC | 37,888 | $105,329 | 0.06% |
| DARK FOREST CAPITAL MANAGEMENT LP | 203,659 | $566,172 | 0.05% |
| Bell & Brown Wealth Advisors, LLC | 20,100 | $55,878 | 0.03% |
| FISHMAN JAY A LTD/MI | 162,000 | $450,360 | 0.03% |